×
  • Select the area you would like to search.
  • ACTIVE INVESTIGATIONS Search for current projects using the investigator's name, institution, or keywords.
  • EXPERTS KNOWLEDGE BASE Enter keywords to search a list of questions and answers received and processed by the ADNI team.
  • ADNI PDFS Search any ADNI publication pdf by author, keyword, or PMID. Use an asterisk only to view all pdfs.
Filter results by:
Year Range:

-
Journal
Authors

3393 Total Publications

Discovery and use of efficient biomarkers for objective disease state assessment in Alzheimer’s disease
van Gils M1, Koikkalainen J, Mattila J, Herukka S, Lotjonen J, Soininen H.
PMID: 21095977 ; 2010; Journal Int J Geriatr Psychiatry; vol. 30; no. 2; pp. 192-200; doi:10.1109/IEMBS.2010.5626311
Reduced sample sizes for atrophy outcomes in Alzheimer's disease trials: baseline adjustment
Schott, J. M., Bartlett, J. W., Barnes, J., Leung, K. K., Ourselin, S., & Fox, N. C.
PMID: 20620665 ; PMCID:2947486 ; 2010; Journal Neurobiology of Aging; vol. 31; no. 8; pp. 1452-62; doi:10.1016/j.neurobiolaging.2010.04.011
Effects of BDNF Val66Met polymorphism on brain metabolism in Alzheimer’s disease
Xu, C., Wang, Z., Fan, M., Liu, B., Song, M., Zhen, X., & Jiang, T.
PMID: 20613678 ; PMCID:2954459 ; 2010; Journal Neuroreport; vol. 21; no. 12; pp. 802-7; doi:10.1097/WNR.0b013e32833ccaf4
The Alzheimer's disease neuroimaging initiative: perspectives of the Industry Scientific Advisory Board
Schmidt ME1, Siemers E, Snyder PJ, Potter WZ, Cole P, Soares H.
PMID: 20451878 ; 2010; Journal Alzheimers Dement; vol. 6; no. 3; pp. 286-90; doi:10.1016/j.jalz.2010.03.010
Requiring an amyloid-β1-42 biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials
Schneider, L. S., Kennedy, R. E., & Cutter, G. R.
PMID: 21414558 ; 2010; Journal Alzheimer's and Dementia; vol. 6; no. 5; pp. 367-77; doi:10.1016/j.jalz.2010.07.004
Requiring an amyloid-β1-42 biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials
Schneider, L. S., Kennedy, R. E., & Cutter, G. R.
PMID: 21414558 ; 2010; Journal Alzheimer's and Dementia; vol. 6; no. 5; pp. 367-77; doi:10.1016/j.jalz.2010.07.004
Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans
Saykin, A. J., Shen, L., Foroud, T. M., Potkin, S. G., Swaminathan, S., Kim, S., … Weiner, M. W.
PMID: 20451875 ; PMCID:2868595 ; 2010; Journal Alzheimer's and Dementia; vol. 6; no. 3; pp. 265-73; doi:10.1016/j.jalz.2010.03.013
Replication of CLU, CR1 and PICALM associations with Alzheimer’s disease
Carrasquillo MM1, Belbin O, Hunter TA, Ma L, Bisceglio GD, Zou F, Crook JE, Pankratz VS, Dickson DW, Graff-Radford NR, Petersen RC, Morgan K, Younkin SG
PMID: 20554627 ; PMCID:2919638 ; 2010; Journal Arch Neurol; vol. 67; no. 8; pp. 961-4; doi:10.1001/archneurol.2010.147
Level of Executive Function Influences Verbal Memory in Amnestic Mild Cognitive Impairment and Predicts Prefrontal and Posterior Cingulate Thickness
Chang, Y.-L., Jacobson, M. W., Fennema-Notestine, C., Hagler, D. J., Jennings, R. G., Dale, A. M., & McEvoy, L. K.
PMID: 19776343 ; PMCID:2912652 ; 2010; Journal Cerebral Cortex; vol. 20; no. 6; pp. 1305-13; doi:10.1093/cercor/bhp192
Brain substrates of learning and retention in mild cognitive impairment diagnosis and progression to AlzheimerÃs disease
Chang, Y. L., Bondi, M. W., Fennema-Notestine, C., McEvoy, L. K., Hagler, D. J., Jacobson, M. W., & Dale, A. M.
PMID: 20034503 ; PMCID:2851550 ; 2010; Journal Neuropsychologia; vol. 48; no. 5; pp. 1237-1247; doi:10.1016/j.neuropsychologia.2009.12.024